| DDP ip Combined With AG in PDAC With Peritoneal Metastasis (NCT05222204) | Fudan University | 2022-05-15 |
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (NCT04493632) | OncoSil Medical Limited | 2022-04-12 |
| Percutaneous Versus EUS FNAC in Pancreatic Masses (NCT04623749) | Ola Kamal Mohammed Galal | 2021-12-01 |
| Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms (NCT05259384) | Peking Union Medical College Hospital | 2021-04-17 |
| Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer (NCT04718701) | The First Affiliated Hospital with Nanjing Medical University | 2021-04-01 |
| Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy (NCT04662346) | University of Pisa | 2020-12-01 |
| MRE for Diagnosis of Pancreatic Masses (NCT06526442) | Yu Shi | 2020-10-09 |
| Endoscopic Ultrasound Radiofrequency Ablation, Database Repository (NCT04693754) | Indiana University | 2020-07-01 |
| Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers (NCT04239573) | ECOG-ACRIN Cancer Research Group | 2020-06-16 |
| Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions (NCT04843956) | Hospital Universitario Dr. Jose E. Gonzalez | 2020-01-08 |
| Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions (NCT04164017) | Centro Hospitalar De São João, E.P.E. | 2019-06-01 |
| EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip Needle (NCT03622229) | Azienda Ospedaliera Universitaria Integrata Verona | 2018-11-01 |
| Pancreatic Cancer Dietary Assessment Study (NCT03616431) | The Christie NHS Foundation Trust | 2018-07-03 |
| Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer (NCT05745415) | Yonsei University | 2018-03-29 |
| EUS-FNB With ROSE Vs. EUS-FNB Without ROSE (NCT03322592) | Azienda Ospedaliera Universitaria Integrata Verona | 2018-03-29 |
| Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer (NCT03310632) | Golden Biotechnology Corporation | 2017-12-01 |
| Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study (NCT03033225) | Mayo Clinic | 2017-05-31 |
| The Effect of Application of TachoSil® in Pancreatoduodenectomy (NCT03269955) | Asan Medical Center | 2017-02-27 |
| Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses (NCT02910960) | AdventHealth | 2016-12-01 |
| Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses (NCT02911974) | AdventHealth | 2016-08-01 |
| CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy (NCT02791503) | Dr. M.R. Meijerink | 2016-05-30 |
| Delayed Gastric Emptying After Pancreatic Surgery (NCT07382791) | National Taiwan University Hospital | 2016-01-01 |
| Endocrine-exocrine Functions and Prognosis After Pancreatectomy (NCT07396662) | National Taiwan University Hospital | 2016-01-01 |
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients (NCT02602067) | sigma-tau i.f.r. S.p.A. | 2015-11-01 |
| In Vitro Models of Liver and Pancreatic Cancer (NCT02436564) | Cambridge University Hospitals NHS Foundation Trust | 2015-07-01 |
| Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients (NCT02456051) | University of Roma La Sapienza | 2015-04-01 |
| Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer (NCT03807999) | Hacettepe University | 2015-02-19 |
| RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses (NCT02092519) | Changi General Hospital | 2013-04-01 |
| Trial Comparing 19 and 25-gauge EUS-FNA Needles (NCT01677312) | AdventHealth | 2012-08-01 |
| The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial. (NCT01996540) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2012-08-01 |
| Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer (NCT02900950) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2012-06-01 |
| Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) (NCT01420874) | Barbara Ann Karmanos Cancer Institute | 2011-08-17 |
| Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle (NCT02181140) | Universitätsklinikum Hamburg-Eppendorf | 2011-08-01 |
| 22G FNA Needle vs. 22G ProCore Needle (NCT01394159) | AdventHealth | 2011-07-01 |
| Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic Mass (NCT01354795) | Samsung Medical Center | 2010-09-01 |
| Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin (NCT00958841) | Novartis Pharmaceuticals | 2009-09-01 |
| A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas (NCT00711191) | Hoffmann-La Roche | 2008-06-01 |
| S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen (NCT00602745) | Sanofi | 2008-02-01 |
| Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer (NCT00574275) | Sanofi | 2007-12-01 |
| Tight Glycemic Control by Artificial Pancreas (NCT00657995) | Kochi University | 2007-04-01 |
| Cancer of the Pancreas Screening Study (CAPS 3) (NCT00438906) | Johns Hopkins University | 2006-12-01 |
| A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer (NCT00436423) | Korea University Anam Hospital | 2006-03-01 |
| Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms (NCT00666926) | Verastem, Inc. | 2005-12-01 |
| Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer (NCT00267020) | Eli Lilly and Company | 2005-12-01 |
| A Study of MLN8054 in Patients With Advanced Solid Tumors (NCT00249301) | Millennium Pharmaceuticals, Inc. | 2005-10-01 |
| Cancer Detection in Pancreatic Cysts (NCT00222898) | University of Pittsburgh | 2004-06-01 |
| Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes (NCT07252570) | Centre Hospitalier Universitaire de Nice | 2004-04-08 |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 (NCT00034281) | Takeda | 2002-06-01 |
| Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy (NCT01278381) | Università Vita-Salute San Raffaele | 2002-01-01 |
| Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas (NCT00005926) | National Cancer Institute (NCI) | 2000-06-01 |